CLINICAL_TRIALS
trial_result
· 2020-10-29
Clinical Trial Update: Vaccination Plus Ontak in Patients With Metastatic Melanoma [Phase 2]
Summary
Phase 2 clinical trial update for vaccination plus Ontak in metastatic melanoma has been terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2020-10-29